Pfizer May Expand Generic Presence, Building On Greenstone
This article was originally published in The Pink Sheet Daily
Executive Summary
Pfizer is assessing "opportunities in the area of generic markets," Global Pharmaceuticals President Karen Katen says. The company's recent launch of an "authorized" generic gabapentin is a "watershed moment."